| Recruitment of Minorities in the PLCO Trial |
Paul Pinsky |
NCI, DCP, EDRG |
PLCO |
Jul 1, 2006 |
2006-0312 |
| Diagnostic Procedures Following Lung Cancer Screens with non-Cancer Abnormalities |
Lois Lamerato |
Henry Ford Health System |
PLCO |
Jul 1, 2006 |
2006-0315 |
| Questionnaire Risk Factors and Multiple Disease Outcomes in PLCO |
Wen-Yi Huang |
NCI, DCEG, OEEB |
PLCO |
Jul 1, 2006 |
2006-0321 |
| Serum Protein Markers of Early Oncogenic Events: A Pre-Diagnostic Study of Multiple Myeloma |
Ola Landgren |
NCI, DCEG, GEB |
PLCO |
Jun 7, 2006 |
2005-0017 |
| Chlamydia pneumoniae infection, chronic inflammation and risk of lung cancer |
Anil Chaturvedi |
NCI, DCEG, IIB |
PLCO |
Apr 21, 2006 |
2005-0014 |
| Serum Levels of Cytokines, Other Immunologic Markers and non-Hodgkin Lymphoma: A Nested Case-Control Study in the PLCO Trial |
Mark Purdue |
NCI, DCEG, OEEB |
PLCO |
Apr 21, 2006 |
2005-0015 |
| Genetic variation in the vitamin E blood transport, cellular uptake, and metabolism pathway and prostate cancer risk |
Demetrius Albanes |
Extramural |
PLCO |
Apr 21, 2006 |
2005-0018 |
| Serum 25-hydroxyvitamin D, dietary vitamin D and non-Hodgkin Lymphoma: a Nested Case Control Study in the PLCO Trial |
Mark Purdue |
NCI, DCEG, OEEB |
PLCO |
Apr 21, 2006 |
2005-0021 |
| Insulin Resistance-Related Metabolic Markers and Pancreatic Cancer Risk |
Rachael Stolzenberg-Solomon |
NCI, DCEG, NEB |
PLCO |
Apr 21, 2006 |
2005-0024 |
| Biomarkers and genetic polymorphisms of one-carbon metabolism and risk of lymphoid cancers |
Unhee Lim |
NCI, DCEG, NEB |
PLCO |
Apr 21, 2006 |
2005-0025 |
| Alcohol intake, genes responsible for alcohol metabolism, and risk of breast cancer in the PLCO cohort |
Catherine McCarty |
Marshfield Clinic Research Foundation |
PLCO |
Apr 21, 2006 |
2005-0027 |
| Measuring carcinogen metabolite levels in long-term smokers and estimating the risk of lung cancer |
Timothy Church |
University of Minnesota |
PLCO |
Apr 21, 2006 |
2005-0029 |
| Evaluating Screening Bias in Risk Factor Studies of Lung Cancer Nested in the PLCO Trial |
Timothy Church |
University of Minnesota |
PLCO |
Mar 31, 2006 |
2006-0307 |
| Observer Variability among PLCO-NLST Radiologists in Interpretation of T-1 CT |
Hrudaya Nath |
University of Alabama at Birmingham |
NLST |
Feb 20, 2006 |
2006-00324 |
| Observer Variability among PLCO-NLST Radiologists in Interpretation of T-0 CXR |
Hrudaya Nath |
University of Alabama at Birmingham |
NLST |
Feb 20, 2006 |
2006-00391 |
| Cell Cycle Variants and Metastatic Prostate Cancer Risk |
Adam Kibel |
Washington University |
PLCO |
Aug 17, 2005 |
2005-0001 |
| Chromosomal aberrations in cultured peripheral blood lymphocytes and subsequent risk of leukemia and lymphoma |
Nathaniel Rothman |
- |
PLCO |
Aug 17, 2005 |
2005-0002 |
| C-GEMS: Cancer Genetic Markers of Susceptibility A Strategic Initiative to Identify Novel Genetic Determinants of Cancer |
Mitchell Machiela |
NCI, DCEG, LGS |
PLCO |
Aug 17, 2005 |
2005-0003 |
| Telomere length, mitochondrial DNA mass, and risk for major chronic diseases |
Richard Hayes |
New York University |
PLCO |
Aug 17, 2005 |
2005-0006 |
| Breast Cancer: Molecular Epidemiology in the PLCO EEMS Cohort - Hormones and Growth Factors |
Regina Ziegler |
NCI, DCEG, EBP |
PLCO |
Aug 17, 2005 |
2005-0007 |
